Computer-aided detection (CAD) technology developer iCAD posted a decrease in sales and a net loss for its fiscal 2005 second quarter.
For the period (end-June 30) the Nashua, NH-based firm reported revenue of $4.2 million, a downturn compared with sales of $5.6 million for the same quarter in fiscal 2004.
The company posted a net loss of $1.1 million for the quarter, compared with net income of $46,000 in the same period a year ago.
The CAD developer said that legal expenses of approximately $535,000, associated principally with its patent arbitration proceedings, significantly contributed to the current loss.
By AuntMinnie.com staff writers
July 28, 2005
Related Reading
iCAD, SourceOne renew contract, July 12, 2005
iCAD adds to Beth Israel presence, June 29, 2005
iCAD nets FDA OK for use with Siemens FFDM, June 13, 2005
iCAD, MRS sign integration deal, May 24, 2005
iCAD posts positive Q1, April 29, 2005
Copyright © 2005 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
